It’s the second time in eight months that a jury has reached that verdict. But Edwin Hardeman’s case against Monsanto is the first to be tried in federal court. And thousands of similar cases are still pending at the federal or state level. “We are very pleased that the jury unanimously held that the Roundup… Read More »
Why do we need to identify and treat women with depression who experience during pregnancy? We have long known that postpartum depression can negatively affect the development of children, the large study from Tuovinen and colleagues clearly shows that depression during pregnancy can have negative effects on the child’s development, predicting lower scores on measures… Read More »
Digital health-focused news involving payers during the third quarter of 2018 comprised a number of different focus areas, ranging from chronic condition management strategies to member engagement to high-profile deals. Read below for MobiHealthNews’ coverage of this sector through July, August and September. Diabetes management and prevention A handful of payer news during this period… Read More »
Uguz and colleagues present data that indicate, in a group of women with panic disorder, neonatal outcomes were worse in the women who did not get treatment. This week’s roundup also features a lot of articles on postpartum depression, addressing an array of factors which increase women’s vulnerability to postpartum psychiatric illness, including adverse life… Read More »
This week, we have some data from our National Pregnancy Registry of Psychiatric Medications looking at infants exposed to quetiapine (Seroquel). Consistent with other studies we have seen recently, there appears to be no increase in risk of major malformations. There is also an interesting paper from DiFlorio and colleagues which assesses risk for postpartum… Read More »